Global Proteomics Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026

The global proteomics market size was garnered $24.43 billion in 2018 and is expected to reach $72.56 billion by 2026, registering a CAGR of 14.7% from 2019 to 2026. The report offers a comprehensive analysis of top winning strategies, recent developments, market dynamics, key segments, and market players.

Rise in prominence of personalized medicine, surge in R&D expenditure, and technological advancements related to proteomics components facilitate the growth in the market. However, scarcity of skilled professionals and high costs related to proteomics components hinder the growth in the market. On the other hand, opportunities related to biomarker identification and advancements in mass spectrometry-based proteomics create new opportunities in the industry.

Reagents segment will continue to lead in terms of revenue by 2026

Based on component, the reagents segment contributed more than three-fourths of the total market share in 2017 and will continue to lead by 2026. This is due to increase in usage as binding materials and precursors of chemical reactions during the protein structure analysis and characterization. However, the instruments segment is expected to grow at the highest CAGR of 16.3% from 2018 to 2026, owing to considerable increase in R&D activities for the development of novel instruments for studying the structure of proteins.

Drug delivery application to maintain its lead position during the forecast period

The drug delivery application contributed nearly three-fifths of the total market share in 2017 and will maintain its lead position during the forecast period. This is due to focus on development of precision medicine, which in turn, result in the growth for drug discovery using proteomics. The research also analyzes disease diagnosis and other applications.

Asia-Pacific to grow the fastest

Asia-Pacific is expected to witness the highest growth rate, with a CAGR of 16.8% from 2018 to 2026, owing to surge in demand for drug discovery and increase in proteomics projects such as the China proteome project in the region. On the other hand, North America accounted for nearly two-fifths of the total market share in 2017 and will maintain its leadership status by 2026. This is due to rise in funding by various organizations, implementation of agreements and collaborations strategies, and surge in R&D investments.

Key Players

Key market players analyzed in the industry include Thermo Fisher Scientific Corporation, Luminex Corporation, Agilent Technologies, Bio-Rad Laboratories, Inc., Danaher Corporation, Inc., Waters Corporation, GE Healthcare, Caprion Proteomics Inc., and PerkinElmer, Inc. They have adopted various strategies including expansions, collaborations, partnerships, joint ventures, mergers & acquisitions, and others to gain a strong position in the market.

Segmentation

By Component

  • Instruments
    • Microarray
    • Spectrometry
      • Mass Spectrometry
      • NMR Spectrometry
    • X-ray Crystallography
    • Chromatography
      • HPLC Systems
      • Ion Chromatography
      • Affinity Chromatography
      • Supercritical Fluid Chromatography
    • Electrophoresis
    • Surface Plasmon Resonance
    • Protein Fractionation Reagents
  • Reagents
    • Microarray
    • Spectroscopy
    • X-ray Crystallography
    • Chromatography
    • Electrophoresis
    • Immunoassay
    • Protein Fractionation Reagents
  • Services

By Application

  • Drug Discovery
  • Disease Diagnosis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

The report analyzes and forecasts the proteomics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report comprises a detailed value chain analysis, which provides a comprehensive view of the global proteomics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.

The study provides a decisive view of the proteomics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

The report provides size (in terms of volume and value) of proteomics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

Report coverage

  • Analysis Period: 2015 – 2026
  • Base Year: 2018
  • Forecast Data: 2019 – 2026
  • Regional Scope: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • Report Coverage: Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.

Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.

The study objectives of this report are:

  • To analyze and study the global proteomics capacity, production, value, consumption, status (2014-2018) and forecast (2019-2026);
  • Focuses on the key proteomics manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content

Section 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Section 2: EXECUTIVE SUMMARY

2.1. Key findings of the study

2.1.1. CXO perspective

Section 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets
3.2.3. Top player positioning

3.3. Porter’s five forces analysis
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Increase in popularity of personalized medicines
3.4.1.2. Upsurge in R&D expenditure
3.4.1.3. Technological advancements associated with proteomics components

3.4.2. Restraints

3.4.2.1. High costs associated with proteomics components
3.4.2.2. Dearth of skilled professionals

3.4.3. Opportunities

3.4.3.1. Lucrative opportunities associated with biomarker identification
3.4.3.2. Developments in mass spectrometry-based proteomics

Section 4: PROTEOMICS MARKET, BY COMPONENT

4.1. Overview

4.1.1. Market size and forecast

4.2. Reagents

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast
4.2.3. Microarray

4.2.3.1. Market size and forecast

4.2.4. Spectrometry

4.2.4.1. Market size and forecast

4.2.5. X-ray crystallography

4.2.5.1. Market size and forecast

4.2.6. Chromatography

4.2.6.1. Market size and forecast

4.2.7. Electrophoresis

4.2.7.1. Market size and forecast

4.2.8. Immunoassay

4.2.8.1. Market size and forecast

4.2.9. Protein fractionation reagents

4.2.9.1. Market size and forecast

4.2.10. Market analysis, by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast
4.3.3. Microarray

4.3.3.1. Market size and forecast

4.3.4. Spectrometry

4.3.4.1. Market size and forecast

4.3.4.1.1. Mass spectrometry

4.3.4.1.1.1. Market size and forecast

4.3.4.1.2. NMR spectrometry

4.3.4.1.2.1. Market size and forecast

4.3.5. Chromatography

4.3.5.1. Market size and forecast

4.3.5.1.1. HPLC systems

4.3.5.1.1.1. Market size and forecast

4.3.5.1.2. Ion chromatography

4.3.5.1.2.1. Market size and forecast

4.3.5.1.3. Affinity chromatography

4.3.5.1.3.1. Market size and forecast

4.3.5.1.4. Supercritical fluid chromatography

4.3.5.1.4.1. Market size and forecast

4.3.6. Electrophoresis

4.3.6.1. Market size and forecast

4.3.7. Surface plasmon resonance

4.3.7.1. Market size and forecast

4.3.8. X-ray crystallography

4.3.8.1. Market size and forecast

4.3.9. Protein fractionation systems

4.3.9.1. Market size and forecast

4.3.10. Market analysis, by country

4.4. Services

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country

Section 5: PROTEOMICS MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Drug discovery

5.2.1. Market size and forecast
5.2.2. Market analysis, by country

5.3. Disease diagnosis

5.3.1. Market size and forecast
5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast
5.4.2. Market analysis, by country

Section 6: PROTEOMICS MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. proteomics market, by component
6.2.2.1.2. U.S. proteomics market, by application

6.2.2.2. Canada

6.2.2.2.1. Canada proteomics market, by component
6.2.2.2.2. Canada proteomics market, by application

6.2.2.3. Mexico

6.2.2.3.1. Mexico proteomics market, by component
6.2.2.3.2. Mexico proteomics market, by application

6.2.3. North America proteomics market, by component
6.2.4. North America proteomics market, by application

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany proteomics market, by component
6.3.2.1.2. Germany proteomics market, by application

6.3.2.2. France

6.3.2.2.1. France proteomics market, by component
6.3.2.2.2. France proteomics market, by application

6.3.2.3. UK

6.3.2.3.1. UK proteomics market, by component
6.3.2.3.2. UK proteomics market, by application

6.3.2.4. Italy

6.3.2.4.1. Italy proteomics market, by component
6.3.2.4.2. ITALY proteomics market, by application

6.3.2.5. Spain

6.3.2.5.1. Spain proteomics market, by component
6.3.2.5.2. Spain proteomics market, by application

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe proteomics market, by component
6.3.2.6.2. Rest of Europe proteomics market, by application

6.3.3. Europe proteomics market, by component
6.3.4. Europe proteomics market, by application

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities

6.4.1.1. Japan

6.4.1.1.1. Japan proteomics market, by component
6.4.1.1.2. Japan proteomics market, by application

6.4.1.2. China

6.4.1.2.1. China proteomics market, by component
6.4.1.2.2. China proteomics market, by application

6.4.1.3. India

6.4.1.3.1. India proteomics market, by component
6.4.1.3.2. India proteomics market, by application

6.4.1.4. Australia

6.4.1.4.1. Australia proteomics market, by component
6.4.1.4.2. Australia proteomics market, by application

6.4.1.5. South Korea

6.4.1.5.1. South Korea proteomics market, by component
6.4.1.5.2. South Korea proteomics market, by application

6.4.1.6. Rest of Asia-Pacific

6.4.1.6.1. Rest of Asia-Pacific proteomics market, by component
6.4.1.6.2. Rest of Asia-Pacific proteomics market, by application

6.4.2. Asia-Pacific proteomics market, by component
6.4.3. Asia-Pacific proteomics market, by application

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil proteomics market, by component
6.5.2.1.2. Brazil proteomics market, by application

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia proteomics market, by component
6.5.2.2.2. Saudi Arabia proteomics market, by application

6.5.2.3. South Africa

6.5.2.3.1. South Africa proteomics market, by component
6.5.2.3.2. South Africa proteomics market, by application

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA proteomics market, by component
6.5.2.4.2. Rest of LAMEA proteomics market, by application

6.5.3. LAMEA proteomics market, by component
6.5.4. LAMEA proteomics market, by application

Section 7: COMPANY PROFILES

7.1. AGILENT TECHNOLOGIES, INC.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments

7.2. DANAHER CORPORATION (BECKMAN COULTER, INC.)

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance

7.3. LI-COR, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product portfolio

7.4. PERKINELMER INC.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance
7.4.6. Key strategic moves and developments

7.5. THERMO FISHER SCIENTIFIC, INC.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. HORIBA, LTD.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance

7.7. BIO-RAD LABORATORIES, INC.

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product type Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. BRUKER CORPORATION (BECKMAN COULTER, INC.)

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product type portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. GE HEALTHCARE (GENERAL ELECTRIC)

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance

7.10. WATERS CORPORATION (BECKMAN COULTER, INC.)

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product type portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers